India-US trade deal has slowed over differences in multiple factors, a report stated. India is reluctant to US' demand to open its market for genetically-modified crops, citing the impact on domestic producers. US is demanding relaxed regulations on medical devices and data localisation, while India seeks exemptions from US tariffs on steel and pharmaceuticals, threatening reciprocal measures.